Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to ease dementia care by tackling diabetes, depression together

NCT ID NCT07543341

Knowledge-focused Sponsor: Possible Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study adapted a behavioral intervention called BECOME to help people with dementia or mild cognitive impairment and their caregivers manage non-communicable diseases (like diabetes and high blood pressure) and common mental health conditions (like depression and anxiety). The study involved 12 participants and focused on making the program accessible for those with cognitive challenges. The goal was to test whether the adapted program is acceptable and feasible, not to measure health outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
behavioral intervention (stress reduction, behavioral activation, motivational interviewing)
What this could lead to
If successful, this could lead to a practical program that helps people with dementia and their caregivers better manage conditions like diabetes, high blood pressure, depression, and anxiety.
What could go wrong
This is a very small pilot study with only 12 participants, focused on adapting and testing feasibility, not on proving effectiveness. The results may not apply to broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

12 people

The number who actually took part.

Started

Jun 2025

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: For Patient participant : * Adult men and women age: ≥60 year with cognitive impairment as indicated at a score of 22 or lower on RUDAS * living in the target wards with no intention of leaving in the next 2.5 yrs * anxiety (HSCL-25 anxiety subscale ≥1.75) and/or depression (HSCL-25 depression subscale ≥1.75) AND * at least one non-communicable disease (NCD) based on WHO PEN criteria: Hypertension (HTN) (SBP ≥130 and/or DBP ≥80) and/or Diabetes Mellitus (DM) (fasting plasma glucose (FPG) ≥126mg/dl or random plasma glucose ≥200mg/dl). For Caregiver: * A family member identified as the primary caregiver of the PwD/MCI * 18 years and older * provide their consent to participate in the study. For Community Health Worker (CHW): * CHW working in the community health program in the identified study cluster. * 18 years and above * provide their consent to participate in the study Exclusion Criteria: For Patient Participants: * Participants who cannot provide consent * Participants who will score 3 or less on the 3-item questionnaire that assesses potential participants' ability to provide consent to participate in research. For Caregiver: \- The primary caregivers who do not provide consent to participate in our study. For Community Health Worker (CHW): \- CHWs who do not provide consent to participate in our study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety dementia depressive disorder diabetes mellitus hypertensive disorder Noncommunicable Diseases Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dementia Mental health Non communicable diseases

Contacts and locations

Locations

  • Possible

    Kathmandu, Bagmati, Nepal

More trials for these conditions

Other studies related to the condition(s) this trial covers.